Cambiar Investors Senior Analyst Charmaine Chan, who holds a doctorate in molecular biophysics and biochemistry from Yale University, details the coronavirus mutation first identified in Southern England and how it may change the nature of the economic re-opening many investors are anticipating.

Cambiar Investors Senior Analyst Charmaine Chan, who holds a doctorate in molecular biophysics and biochemistry from Yale University, details the latest on possible vaccines, the likeliness of a second wave of coronavirus and the next steps for the U.S. on the road to recovery.